BCR and B-cell chronic lymphocytic leukemia: In addition, the finding that the CLL cells from a given patient were clonal, i.e., derived from the same progenitor cell as demonstrated by the utilization of a unique IGHV-IGHD-IGHJ gene rearrangement in each leukemic clone [14], provided a more refined explanation of CLL cell immune incompetence, given that the B cell Receptor (BcR) of the leukemic clone has a restricted specificity and is unable to cover the large repertoire required for the immune defense, even when assuming the normal functioning of the cells.